Trials / Conditions / Advanced Solid Malignancy
Advanced Solid Malignancy
4 registered clinical trials studyying Advanced Solid Malignancy — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | EMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial - 1) NCT06923761 | Grey Wolf Therapeutics | Phase 1 / Phase 2 |
| Completed | Comparison of Two Formulations of AZD5363 and the Effect of Food on Pharmacokinetic Exposure, Safety and Toler NCT01895946 | AstraZeneca | Phase 1 |
| Completed | Open Label Phase 1 Study in Japan for Patient With Advanced Solid Malignancies NCT01353781 | AstraZeneca | Phase 1 |
| Completed | Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Sc NCT01226316 | AstraZeneca | Phase 1 |